Operating Lease, Right-of-Use Asset of Janux Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Janux Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Janux Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $18,402,000, a 4.6% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Janux Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $18,402,000 -$884,000 -4.6% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $18,923,000 -$763,000 -3.9% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $18,462,000 -$1,615,000 -8% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $18,878,000 -$1,583,000 -7.7% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $19,286,000 -$1,552,000 -7.4% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $19,686,000 -$1,522,000 -7.2% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $20,077,000 -$1,494,000 -6.9% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $20,461,000 -$1,466,000 -6.7% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $20,838,000 -$1,441,000 -6.5% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $21,208,000 -$1,455,000 -6.4% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $21,571,000 -$1,189,000 -5.2% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $21,927,000 +$21,797,000 +16767% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $22,279,000 +$22,094,000 +11943% 31 Dec 2022 10-K 08 Mar 2024 2023 FY
Q3 2022 $22,663,000 +$22,425,000 +9422% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $22,760,000 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $130,000 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $185,000 +$185,000 31 Dec 2021 10-K 10 Mar 2023 2022 FY
Q3 2021 $238,000 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q4 2020 $0 31 Dec 2020 10-K 18 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.